Intellia Therapeutics Newsroom

Cathie Wood-Led Ark Invest Continues Shopping For Shopify Stock, Sells $15M Worth Of Jack Dorsey's Block Shares Amid Bitcoin Price Drop

On Tuesday, Cathie Wood's Ark Invest made some significant trades, notably buying shares of Shopify Inc (NYSE:SHOP) and selling off Block Inc (NYSE:SQ) stocks.The Shopify TradeArk Invest's ETFs, inclu

BenzingaMay 14 22:46 ET

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Liquidia Technologies (LQDA) and Pacific Biosciences (PACB)

TipRanksMay 14 13:10 ET

Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Iovance Biotherapeutics (IOVA) and Intellia Therapeutics (NTLA)

TipRanksMay 14 05:20 ET

Express News | Intellia Therapeutics Inc : Morgan Stanley Cuts Target Price to $57.00 From $85.00

ReutersMay 13 08:28 ET

Cantor Picks 14 Undervalued Biotech Stocks Worth a Second Look

Seeking AlphaMay 12 11:00 ET

Intellia Therapeutics Is Maintained at Neutral by Citigroup

Intellia Therapeutics Is Maintained at Neutral by Citigroup

Dow JonesMay 10 17:44 ET

Express News | Citigroup Maintains Neutral on Intellia Therapeutics, Lowers Price Target to $29

BenzingaMay 10 17:34 ET

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 10 15:35 ET

Intellia Therapeutics Q1 2024 Earnings: Aligns With Analyst Projections Amidst Strategic Advances

Yahoo FinanceMay 10 13:16 ET

Intellia Therapeutics Is Maintained at Outperform by BMO Capital

Intellia Therapeutics Is Maintained at Outperform by BMO Capital

Dow JonesMay 10 11:18 ET

Intellia Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 188.07% BMO Capital $62 → $70 Maintains Outperform 04/23/2024 19.34% Wedbush → $29 Reiterates N

BenzingaMay 10 11:06 ET

Intellia Therapeutics: A Promising Buy Rating Supported by Trial Success and Strong Financials

TipRanksMay 10 08:16 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Catalyst Pharma (CPRX), Xenon (XENE) and Intellia Therapeutics (NTLA)

TipRanksMay 10 07:10 ET

Express News | Intellia Therapeutics Inc : BMO Raises Target Price to $70.00 From $62.00

ReutersMay 10 07:01 ET

Express News | Intellia Therapeutics Inc : Guggenheim Cuts Target Price to $55 From $64

ReutersMay 10 06:32 ET

Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA)

TipRanksMay 10 05:10 ET

JMP Securities Remains a Hold on Intellia Therapeutics (NTLA)

TipRanksMay 10 00:57 ET

Express News | Intellia Therapeutics Inc : Raymond James Raises Target Price to $58 From $57

ReutersMay 10 00:42 ET

Express News | Intellia Therapeutics Inc : Leerink Partners Cuts Target Price to $70 From $71

ReutersMay 9 23:49 ET

Intellia Therapeutics | 10-Q: Quarterly report

Futu NewsMay 9 16:29 ET · Announcements